Association between Serum Biomarker Profile and Real-World Evidence of Disability in Multiple Sclerosis

被引：0
|
作者：
Zhu, W. [1 ]
Chen, C. [1 ]
Zhang, L. [1 ]
Hoyt, T. [2 ]
Walker, E. [1 ]
Venkatesh, S. [1 ]
Zhang, F. [3 ]
Qureshi, F. [3 ]
Foley, J. [2 ]
Xia, Z. [1 ]
机构：
[1] Univ Pittsburgh, Neurol, Pittsburgh, PA USA
[2] Rocky Mt Multiple Sclerosis Clin, Salt Lake City, UT USA
[3] Octave Biosci Inc, Assay Dev, Menlo Pk, CA USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2023年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P006
引用
收藏
页码：20 / 21
页数：2
相关论文
共 50 条
  • [21] Association between Serum Biomarkers and Patient-Reported Outcome of Disability in Multiple Sclerosis
    Zhu, W.
    Qureshi, F.
    Zhang, F.
    Foley, J.
    Xia, Z.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (1_SUPPL) : 22 - 22
  • [22] Robust real-world evidence: optimising disease-modifying treatments for multiple sclerosis
    Mcarthur, C.
    Daruwalla, C.
    Jayeskara, M.
    Brown, J. W. L.
    JOURNAL OF NEUROLOGY, 2023, 270 (10) : 5127 - 5129
  • [23] REAL-WORLD EVIDENCE IN MULTIPLE SCLEROSIS (MS): HTA DECISION-MAKING INFLUENCER OR NOT?
    Nanda, S.
    Jindal, S.
    Rohillla, A.
    Mahajan, S.
    Saharia, P.
    VALUE IN HEALTH, 2022, 25 (12) : S344 - S344
  • [24] Real-world evidence for cladribine tablets in multiple sclerosis: further insights into efficacy and safety
    Moser, Tobias
    Ziemssen, Tjalf
    Sellner, Johann
    WIENER MEDIZINISCHE WOCHENSCHRIFT, 2022, 172 (15-16) : 365 - 372
  • [25] Robust real-world evidence: optimising disease-modifying treatments for multiple sclerosis
    C. McArthur
    C. Daruwalla
    M. Jayeskara
    J. W. L. Brown
    Journal of Neurology, 2023, 270 : 5127 - 5129
  • [26] Real-world evidence on the safety and effectiveness of fingolimod in patients with multiple sclerosis from Taiwan
    Yang, Chih-Chao
    Ro, Long-Sun
    Tsai, Nai-Wen
    Lin, Chou-Ching
    Huang, Wen-Nan
    Tsai, Ching-Piao
    Lin, Thy-Sheng
    Su, Jen-Jen
    Huang, Chin-Chang
    Lyu, Rong-Kuo
    Chen, Hsin-Hua
    Lee, Wei-Ju
    Chen, Po-Lin
    Yang, Audrey
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2021, 120 (01) : 542 - 550
  • [27] Longitudinal testing with a multivariate blood serum biomarker panel for multiple sclerosis disease activity: patterns of results in a real-world clinical setting
    Hoyt, T.
    Eubanks, J.
    Qureshi, F.
    Foley, J.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 832 - 832
  • [28] Real-world outcomes of siponimod in multiple sclerosis patients
    Tan, Hongmei
    Quan, Chao
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 1129 - 1129
  • [29] Association Between Gastroesophageal Reflux Disease and Laryngeal Disorders: Real-World Evidence
    Lee, I-Yun
    Kuo, Yu-Jen
    Wu, Ching-Yuan
    Yang, Yao-Hsu
    Shih, Wei-Tai
    Yang, Pei-Rung
    Chen, Ko-Jung
    Tsai, Yao-Te
    Tsai, Ming-Shao
    Chang, Geng-He
    Yang, Ming-Yu
    Hsu, Cheng-Ming
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2025, 172 (01) : 208 - 213
  • [30] Real-World Utilization of a Proteomic Biomarker Panel for Assessing Multiple Sclerosis Disease Activity in an Academic Multiple Sclerosis Clinic with a Diverse Patient Population
    Kilgo, William
    Padarti, Akhil
    Izbicki, Patricia
    Eubanks, James
    Sanchez, Angela
    Qureshi, Ferhan
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 301 - 301
12345